These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Immunopathological and genetic features in slowly progressive insulin-dependent diabetes mellitus and latent autoimmune diabetes in adults. Kobayashi T; Tanaka S; Harii N; Aida K; Shimura H; Ohmori M; Kanesige M; Shimada A; Maruyama T Ann N Y Acad Sci; 2006 Oct; 1079():60-6. PubMed ID: 17130533 [TBL] [Abstract][Full Text] [Related]
7. Type 1 diabetes. Daneman D Lancet; 2006 Mar; 367(9513):847-58. PubMed ID: 16530579 [TBL] [Abstract][Full Text] [Related]
8. [Etiology and pathogenesis of type I diabetes]. Ziegler AG Z Gesamte Inn Med; 1993 Mar; 48(3):100-7. PubMed ID: 8475631 [TBL] [Abstract][Full Text] [Related]
9. Diabetes technology and treatments in the paediatric age group. Shalitin S; Peter Chase H Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816 [TBL] [Abstract][Full Text] [Related]
10. [Immunological aspects of the development and treatment of insulin-dependent diabetes mellitus]. Aleksandrovskiĭ IaA Klin Med (Mosk); 1987 Jul; 65(7):31-7. PubMed ID: 3312797 [No Abstract] [Full Text] [Related]
11. The importance of diabetes registries and clinical biology for the study and treatment of type 1 (insulin-dependent) diabetes mellitus. Gorus FK Verh K Acad Geneeskd Belg; 1996; 58(5):539-86. PubMed ID: 9008403 [TBL] [Abstract][Full Text] [Related]
12. The broad clinical phenotype of Type 1 diabetes at presentation. Merger SR; Leslie RD; Boehm BO Diabet Med; 2013 Feb; 30(2):170-8. PubMed ID: 23075321 [TBL] [Abstract][Full Text] [Related]
13. Technology and the issue of cost/benefit in diabetes. Giannini C; Mohn A; Chiarelli F Diabetes Metab Res Rev; 2009 Sep; 25 Suppl 1():S34-44. PubMed ID: 19662616 [TBL] [Abstract][Full Text] [Related]
14. Care of the child or adolescent with type 1 diabetes. Grey M; Kanner S Nurs Clin North Am; 2000 Mar; 35(1):1-13. PubMed ID: 10673562 [TBL] [Abstract][Full Text] [Related]
15. Stem cell-based therapy for the treatment of Type 1 diabetes mellitus. Krishna KA; Rao GV; Rao KS Regen Med; 2007 Mar; 2(2):171-7. PubMed ID: 17465749 [TBL] [Abstract][Full Text] [Related]
16. [Immunogenetics and new therapies in type I diabetes mellitus]. Gannage-Yared MH J Med Liban; 1999; 47(2):139-43. PubMed ID: 10410471 [No Abstract] [Full Text] [Related]
17. Immunoreactivity to a 64,000 Mr human islet cell antigen in sera from insulin-dependent diabetes mellitus patients and individuals with abnormal glucose tolerance. Baekkeskov S Mol Biol Med; 1986 Apr; 3(2):137-42. PubMed ID: 3526081 [TBL] [Abstract][Full Text] [Related]
18. The pathogenesis, prediction, and prevention of insulin-dependent diabetes mellitus. Muir A; Schatz DA; Maclaren NK Endocrinol Metab Clin North Am; 1992 Jun; 21(2):199-219. PubMed ID: 1612064 [TBL] [Abstract][Full Text] [Related]
19. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes. Naserke HE; Ziegler AG; Lampasona V; Bonifacio E J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731 [TBL] [Abstract][Full Text] [Related]
20. The pathogenesis of insulin-dependent diabetes mellitus. Atkinson MA; Maclaren NK N Engl J Med; 1994 Nov; 331(21):1428-36. PubMed ID: 7969282 [No Abstract] [Full Text] [Related] [Next] [New Search]